James Healy - Insider Trading & Ownership

Entity
Individual
Location
3000 Sand Hill Road, 4 250, Menlo Park, CA
Summary
The estimated net worth of James Healy is at least $223M dollars as of October 29, 2024. James Healy is the Director of Natera, Inc. and owns shares of Natera, Inc. (NTRA) stock worth about $190M. James Healy is the Director of Y-mAbs Therapeutics, Inc. and owns shares of Y-mAbs Therapeutics, Inc. (YMAB) stock worth about $26.7M. James Healy is the Director of ArriVent Biopharma, Inc. and owns shares of ArriVent BioPharma, Inc. (AVBP) stock worth about $6.19M.
All Insider Reports
All Insider Reports

Ownership of James Healy

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NTRA Natera, Inc. Director $190M -$37.8M -16.6% Oct 25, 2024
YMAB Y-mAbs Therapeutics, Inc. Director $26.7M Jun 11, 2024
AVBP ArriVent BioPharma, Inc. Director $6.19M Jan 30, 2024
KRTX Karuna Therapeutics, Inc. Director $0 Mar 18, 2024
BIOA BioAge Labs, Inc. Director Sep 25, 2024
BOLT Bolt Biotherapeutics, Inc. Director Jun 12, 2024
CINC CinCor Pharma, Inc. Director, 10%+ Owner Nov 28, 2022
CHRS Coherus BioSciences, Inc. Director Jan 7, 2022
RAPP Rapport Therapeutics, Inc. Director Jul 1, 2024

Insider Transactions Reported by James Healy:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.